Amer Zeidan: When oncologists finally discovered they can make much more with less stress and more time for their families

Amer Zeidan shared on X/Twitter:

”These locum opportunities have become so lucrative for oncologists, and makes you wonder if they reflect increasing burn out, early retirements and leaving to non-clinical jobs when oncologists finally discovered they can make much more with less stress and more time for their families.”

Source: Amer Zeidan/X

Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.